Home » Topics » Regulatory

Regulatory
RSS

Manufacturing approval obtained for Onoact

July 31, 2002

E.U. approval for cancer imaging agent Flucis

July 30, 2002

ADVENT trial results support expanded indications for Niaspan

July 30, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Eligard 22.5 mg approved for advanced prostate cancer

July 25, 2002

Serono to develop anastrozole for female infertility

July 25, 2002

Nasonex indication expanded to include children as young as two years

July 23, 2002

Aranesp approved for chemotherapy-induced anemia

July 23, 2002

Xyrem approved for cataplexy associated with narcolepsy

July 22, 2002

Busulfex to undergo clinical evaluation in Japan in hematopoietic stem cell transplantation

July 19, 2002

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...